CS Diagnostics Corp. (CSDX)
OTCMKTS · Delayed Price · Currency is USD
0.0700
0.00 (0.00%)
Jul 31, 2026, 10:27 AM EST

CS Diagnostics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2009FY 2008
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '09 Dec '08
Revenue
0.20.20.110.13--
Revenue Growth
83.93%83.93%-12.00%---
Gross Profit
0.20.20.110.13--
Operating Income
0.070.070-0.02-0.23-0.36
Net Income
0.070.070-0.02-0.27-0.4
Earnings Per Share
0.000.000.00-0.00-2.79-4.16
EPS Growth
5580.00%5580.00%----

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2009FY 2008
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '09 Dec '08
Cash & Investments
0.010.0100.020.040.04
Total Debt
------
Net Cash (Debt)
0.010.0100.020.040.04
Net Cash Growth
1259.88%1259.88%-97.54%-45.52%-0.01%-
Net Cash Per Share
0.000.00-0.000.390.39

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2009FY 2008
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '09 Dec '08
Operating Cash Flow
0.010.010.010.01-0-0.73
Capital Expenditures
------0.01
Free Cash Flow
0.010.010.010.01-0-0.74
Free Cash Flow Growth
-42.78%-42.78%18.77%---

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2009FY 2008
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '09 Dec '08
Gross Margin
100.00%100.00%100.00%100.00%--
Operating Margin
34.91%34.91%0.69%-17.45%--
Pretax Margin
34.91%34.91%0.69%-17.45%--
Profit Margin
34.91%34.91%0.69%-17.45%--
FCF Margin
3.09%3.09%9.95%7.37%--

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2009FY 2008
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '09 Dec '08
PE Ratio
246.481073.77197840.52---
P/FCF Ratio
2772.4112115.4313648.5042.54--
PS Ratio
85.78374.871357.453.14--